IeumBio Expands into Pharma through Collaborative Research with Daewoong Pharmaceutical
Page Info
Content
ieumBio has entered into a collaborative research partnership with Daewoong Pharmaceutical.
This collaboration represents a key step in validating our killifish-based platform within a real-world pharmaceutical R&D environment.
By combining ieumBio’s rapid lifespan evaluation system with Daewoong’s drug development expertise, we aim to explore more efficient approaches to testing longevity interventions.
As the demand for faster and more scalable models continues to grow, we believe this partnership reflects a broader shift in how longevity and drug discovery research are conducted.
We are excited to work alongside an industry leader to advance this field.
Feel free to reach out if you're exploring new approaches in longevity or drug discovery.
#longevity #biotech #drugdiscovery #aging #pharma #innovation #research
- PrevieumBio Selected for KIC DC Tech Launch 2026 to Accelerate US Market Entry 26.04.28
- NextAdvisory Board Announcement 26.03.19
